Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2002
09/18/2002EP1240202A2 Inhibitors of complement activation, their preparation and use
09/18/2002EP1240199A2 Method for screening of appetite control agents
09/18/2002EP1240197A1 Interleukin-1 receptor antagonist-like molecules and uses thereof
09/18/2002EP1240196A2 Basolateral sorting signal based on scf peptide and inhibitors thereof
09/18/2002EP1240195A2 Polynucleotides and polypeptides encoded thereby
09/18/2002EP1240194A2 Novel human protein kinases and protein kinase-like enzymes
09/18/2002EP1240192A2 Attenuated microorganisms for the treatment of infection
09/18/2002EP1240191A1 P. gingivalis antigenic composition
09/18/2002EP1240189A2 Hepatitis virus sentinel virus i (svi)
09/18/2002EP1240187A2 Novel human kinase proteins and polynucleotides encoding the same
09/18/2002EP1240186A2 Improvements in or relating to immune responses to hiv
09/18/2002EP1240185A2 Herbicide target genes and methods
09/18/2002EP1240183A2 Mammalian genes; related reagents and methods
09/18/2002EP1240178A2 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides
09/18/2002EP1239961A2 Devices and methods for making bioarrays
09/18/2002EP1239950A2 Cell arrays and the uses thereof
09/18/2002EP1239885A1 Interventions to mimic the effects of calorie restriction
09/18/2002EP1239874A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
09/18/2002EP1239872A2 Enzyme treatment for infection
09/18/2002EP1239870A1 Interleukin-1 receptor antagonist-like molecules and uses thereof
09/18/2002EP1239869A2 Tweak receptor
09/18/2002EP1239866A1 INDUCING CELLULAR IMMUNE RESPONSES TO HER2/neu USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS
09/18/2002EP1239848A2 Compositions and methods for modulating hdl cholesterol and triglyceride levels
09/18/2002EP1239836A1 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same
09/18/2002EP1239776A2 Surgical needle with weeping tip and method of use
09/18/2002EP1239739A1 The removal of extraneous substances from biological fluids containing nucleic acids and the recovery of nucleic acids
09/18/2002EP1212339A4 2'-o-acetamido modified monomers and oligomers
09/18/2002EP1187840A4 Methods of dna purification and purified dna
09/18/2002EP1185711A4 Compositions and methods for labeling of nucleic acid molecules
09/18/2002EP1180113A4 Oligonucleotides having a-dna form and b-dna form conformational geometry
09/18/2002EP1137768A4 Human hybrid host cell for mammalian gene expression
09/18/2002EP1088095A4 Novel molecules of the t110-related protein family and uses thereof
09/18/2002EP1053352B1 Mismatch detection techniques
09/18/2002EP0979239A4 Prevention and treatment of hepatocellular cancer
09/18/2002EP0973943B1 Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes
09/18/2002EP0954613B1 Reporter cell line system for detecting cytomegalovirus and identifying modulators of viral gene expression
09/18/2002EP0943015B1 Method and apparatus for preparing sample cartridges for a particle acceleration device
09/18/2002EP0923308B1 Purification of biologically active peptides from milk
09/18/2002EP0914420A4 Herbicide resistant rice
09/18/2002EP0907750B1 Three-hybrid screening assay
09/18/2002EP0859864B1 Method and apparatus for determining the existence of a mutation
09/18/2002EP0842267B1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME
09/18/2002EP0789763B1 Icam-4 materials and methods
09/18/2002EP0764217B1 Use of a specific marker for detecting Salmonella with PCR
09/18/2002EP0755401B1 Apparatus for isolating cellular components
09/18/2002EP0750681B1 Assays for immunosuppressants
09/18/2002EP0693936B1 Cloned leptospira outer membrane protein
09/18/2002EP0648263B1 Lipases from hyphozyma
09/18/2002EP0614486B1 Targeted delivery of virus vector to mammalian cells
09/18/2002EP0592582B1 Monoclonal antibody to lymphocyte-associated cell surface protein
09/18/2002EP0575357B1 Human follicle stimulating hormone receptor
09/18/2002CN1370242A Genomic profiling: repid method for testing complex biological sample for presence of many types of organisms
09/18/2002CN1370240A Regulation system of expression using nuclear PPAR receptors
09/18/2002CN1370239A Streptomyces avermitilis gene directing ratio of B2:B1 avermectins
09/18/2002CN1370238A Human poly(ADP-ribose) polymerase 2 materials and methods
09/18/2002CN1370237A Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of non-essential gene
09/18/2002CN1370233A ERS-genes, method of screening for chemical compounds capable of inducing ERS in plants
09/18/2002CN1370232A Methods for making APO-2 ligand using divalent metal ions
09/18/2002CN1370231A CASB618 polynucleotides and polypeptides and their use
09/18/2002CN1370230A Sumultaneous isolation and quantitation of DNA
09/18/2002CN1370229A Nucleic acid fragment and vector contg. halogenase and method for halogenation of chemical compounds
09/18/2002CN1370228A Process for producing L-lysine
09/18/2002CN1370182A Compounds and methods for therapy and diagnosis of lung cancer
09/18/2002CN1370178A Polynucletoides and polypeptides encoded through distantly homogous to heparanase
09/18/2002CN1370083A Ninovasive genetic immnization, expression products therefrom, and uses thereof
09/18/2002CN1369563A Process for configuring local bio-reactor of animal's mammary gland
09/18/2002CN1369562A Plant expression carrier with dual insect-resisting genes and its application
09/18/2002CN1369561A Cell factor CK-HA and its variant with hematogenesis promoting and immunoregulating functions
09/18/2002CN1369560A Silk fibroin transgenic cotton fibre and genetic engineering process for preparing it
09/18/2002CN1369559A Hydantoin hydrolae and its application
09/18/2002CN1369558A Trichoderma chitinase and gene for expressing it
09/18/2002CN1369554A Glycotransferase trasition expression strain of protean strep to coccus and its configuration process
09/18/2002CN1369506A Human Protein for promoting transform of 3T3 cell and its coding sequence
09/18/2002CN1369505A Human protein for promoting transform of 3T3 cell and its coding sequence
09/18/2002CN1369503A Gene for controling transform of mouseearcress from monocyclic flower to polycyclic flower
09/18/2002CN1369502A Specific gene for controlling thickness of moaseearcress' stem
09/18/2002CN1369501A Gene of 26S proteinase alpha subunit for regulating degradation of mouseearcress' abnormal protein
09/18/2002CN1091111C Structure and usage of antisense oligonucleotide for treating diseases correlative to hepatitis C virus
09/17/2002WO2001070751A1 Reactive monomers for the oligonucleotide and polynucleotide synthesis, modified oligonucleotides and polynucleotides, and a method for producing the same
09/17/2002US6453245 Method and apparatus for identifying, classifying, or quantifying protein sequences in a sample without sequencing
09/17/2002US6453243 Method for displaying result of hybridization experiment using biochip and method for evaluating experimental error of hybridization experiment
09/17/2002US6453242 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
09/17/2002US6452070 Methods of using viral replicase polynucleotides and polypeptides
09/17/2002US6452069 SF3 promoter and methods of use
09/17/2002US6452068 Transforming plant cell with vector comprising dna encoding regulatory sequence of estrogen receptor; and transactivating and binding domains; growing in presence of inducer; excising shoots
09/17/2002US6452067 Methods to assay for post-transcriptional suppression of gene expression
09/17/2002US6452066 GENOMIC DNA FRAGMENTS CONTAINING REGULATORY AND CODING SEQUENCES FOR THE β2-SUBUNIT OF THE NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR AND TRANSGENIC ANIMALS MADE USING THESE FRAGMENTS OR MUTATED FRAGMENTS
09/17/2002US6452065 Transgenic mouse expressing non-native wild-type and familial Alzheimer's Disease mutant presenilin 1 protein on native presenilin 1 null background
09/17/2002US6451997 Kits for detecting chromosomal rearrangements
09/17/2002US6451995 Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods
09/17/2002US6451994 Polypeptides, polynucleotides; drug screening; diagnosing alzheimer*s, parkinson*s, huntington*s, and creutzfelt-jacob disease; amyotrophic lateral sclerosis, cystic fibrosis
09/17/2002US6451992 Antithrombin activity; veterinary vaccines
09/17/2002US6451986 Conjugating a protein with polyethylene glycol (peg), by deleting amino residue(s); for example, replacing protein arginine residues with lysine residues that provide a peg attachment site; bioactivity
09/17/2002US6451982 Polypeptide with amino acid sequences grafted into human heavy and light chain variable regions
09/17/2002US6451981 Inhibitor of cellular adhesion, migration or infiltration into areas of tissue damage, injury, or transplant
09/17/2002US6451976 Bi-or multifunctional molecules based on a dendroaspin scaffold
09/17/2002US6451968 Hoogsteen type base pairing in triplex motif; diagnosis; heat resistance; detection of point mutations, restriction enzyme sites, and transcription inhibition
09/17/2002US6451840 Regulation of T cell-mediated immunity by tryptophan
09/17/2002US6451770 A liquid jet intradermal administration apparatus that administers an immunogenic composition or vaccine to an animal: without a needle, and into the epidermis, dermis and/or hypodermis; wherein the apparatus includes an
09/17/2002US6451769 Compositions and methods for administering Borrelia DNA